Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2023 | 12-2022 | 10-2022 | 09-2022 | 07-2022 | |
| Operating Expenses | 4,633 | 492 | 18,087 | 523 | 371 |
| Operating Income | -4,633 | -492 | -18,087 | -523 | -371 |
| Interest Expense | 1,175 | 0 | 0 | 0 | 0 |
| Other Income | -1,610 | 1,112 | -5,764 | 596 | 113 |
| Pre-tax Income | -7,418 | 620 | -23,851 | 73 | -258 |
| Net Income Continuous | -7,418 | 620 | -23,873 | 73 | -258 |
| Net Income | $-7,418 | $620 | $-23,873 | $73 | $-258 |
| EPS Basic Total Ops | -13.29 | 0.05 | -44.25 | 0.00 | N/A |
| EPS Basic Continuous Ops | -11.39 | 0.20 | -37.15 | 0.02 | N/A |
| EPS Diluted Total Ops | -13.29 | 0.05 | -44.25 | 0.00 | N/A |
| EPS Diluted Continuous Ops | -11.39 | 0.20 | -37.15 | 0.02 | N/A |
| EBITDA(a) | $-4,587 | $-492 | $-17,849 | $-523 | $-371 |